NYSE:BAX - Baxter International Stock Price, Forecast & News

Baxter International's stock was trading at $77.97 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BAX shares have increased by 2.3% and is now trading at $79.79. View which stocks have been mosted impacted by Coronavirus.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 6 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Baxter International.

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, April 23rd 2020. View our earnings forecast for Baxter International.

Baxter International Inc (NYSE:BAX) released its quarterly earnings results on Tuesday, March, 17th. The medical instruments supplier reported $0.97 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.88 by $0.09. The medical instruments supplier had revenue of $2.85 billion for the quarter, compared to analysts' expectations of $2.87 billion. Baxter International had a net margin of 9.12% and a return on equity of 22.41%. Baxter International's revenue for the quarter was up .4% on a year-over-year basis. During the same period last year, the firm posted $0.80 earnings per share. View Baxter International's earnings history.

Baxter International announced a quarterly dividend on Tuesday, February 18th. Investors of record on Friday, February 28th will be given a dividend of $0.22 per share on Wednesday, April 1st. This represents a $0.88 annualized dividend and a dividend yield of 1.10%. The ex-dividend date is Thursday, February 27th. View Baxter International's dividend history.

Baxter International announced that its board has approved a stock repurchase plan on Tuesday, November 13th 2018, which authorizes the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 6.1% of its shares through open market purchases. Shares buyback plans are usually a sign that the company's board of directors believes its stock is undervalued.

Baxter International updated its first quarter earnings guidance on Tuesday, March, 17th. The company provided earnings per share (EPS) guidance of $0.72-0.74 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.81.

19 analysts have issued 1 year price objectives for Baxter International's shares. Their forecasts range from $75.00 to $104.00. On average, they expect Baxter International's share price to reach $92.89 in the next year. This suggests a possible upside of 16.4% from the stock's current price. View analysts' price targets for Baxter International.

News headlines about BAX stock have trended somewhat positive recently, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Baxter International earned a coverage optimism score of 1.2 on InfoTrie's scale. They also assigned media coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutBaxter International.

Baxter International saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 6,344,100 shares, an increase of 27.9% from the February 27th total of 4,960,000 shares. Based on an average trading volume of 2,620,000 shares, the short-interest ratio is presently 2.4 days. Currently, 1.3% of the company's stock are short sold. View Baxter International's Current Options Chain.

Some companies that are related to Baxter International include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Insulet (PODD), Steris (STE), Varian Medical Systems (VAR) and Masimo (MASI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Honeywell International (HON), Johnson & Johnson (JNJ), Cisco Systems (CSCO), AT&T (T), BlackRock (BLK), Pfizer (PFE), Verizon Communications (VZ), Alibaba Group (BABA) and Home Depot (HD).

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International's stock is owned by a variety of institutional and retail investors. Top institutional investors include Wealth Quarterback LLC (14.07%), State Street Corp (4.68%), Third Point LLC (3.43%), FMR LLC (2.64%), Geode Capital Management LLC (1.41%) and Nuveen Asset Management LLC (1.40%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View institutional ownership trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Bessemer Group Inc., Schroder Investment Management Group, Bank of New York Mellon Corp, AQR Capital Management LLC, Janus Henderson Group PLC, Los Angeles Capital Management & Equity Research Inc., and Argent Capital Management LLC. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Jacqueline Kunzler, James R Gavin III, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc, and Thomas T Stallkamp. View insider buying and selling activity for Baxter International.

BAX stock was bought by a variety of institutional investors in the last quarter, including Wealth Quarterback LLC, Norges Bank, Capital International Investors, Nuveen Asset Management LLC, Bank of Montreal Can, Third Point LLC, Alyeska Investment Group L.P., and New York State Common Retirement Fund. View insider buying and selling activity for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $79.79.

Baxter International has a market capitalization of $40.47 billion and generates $11.36 billion in revenue each year. The medical instruments supplier earns $1.00 billion in net income (profit) each year or $3.31 on an earnings per share basis. Baxter International employs 50,000 workers across the globe. View additional information about Baxter International.

The official website for Baxter International is http://www.baxter.com/.

Baxter International's mailing address is One Baxter Parkway, Deerfield IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]